|
LoxapineDrug - Loxapine The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Loxapine Succinate
Strength -
EQ 5MG BASE
Applicant -
MYLAN
New Drug Application (NDA) Number -
076762
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Nov 1, 2004
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Mylan Pharmaceuticals Inc
Loxapine
Loxapine Eq 50mg Base Capsule; Oral
Loxapine Eq 5mg Base Capsule; Oral Mevacor 40mg Tablet; Oral Advicor 20mg;1gm Tablet, Extended Release; Oral Advicor 20mg;500mg Tablet, Extended Release; Oral Advicor 20mg;750mg Tablet, Extended Release; Oral Loxitane C Eq 25mg Base/ml Concentrate; Oral Loxitane Im Eq 50mg Base/ml Injectable; Injection Loxapine Eq 10mg Base Capsule; Oral Loxapine Eq 25mg Base Capsule; Oral NewDrugInformation |